{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:25:53Z","timestamp":1792157153759,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":786,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.24875\/ric.23000112","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T22:43:01Z","timestamp":1688596981000},"page":"105-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin"],"prefix":"10.1016","volume":"75","author":[{"given":"Ana","family":"Canseco-Alba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Rodriguez-Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.24875\/RIC.23000112_bib1","first-page":"S163","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.24875\/RIC.23000112_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"10.24875\/RIC.23000112_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"2013"},{"key":"10.24875\/RIC.23000112_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.24875\/RIC.23000112_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-pharmtox-010716-104615","article-title":"Don\u2019t worry, be happy: endocannabinoids and Cannabis at the intersection of stress and reward","volume":"57","author":"Volkow","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.24875\/RIC.23000112_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1874473711104040241","article-title":"Cannabinoid hyperemesis syndrome","volume":"4","author":"Galli","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"10.24875\/RIC.23000112_bib7","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/jcp.27725","article-title":"Medical Cannabis: a plurimillennial history of an evergreen","volume":"234","author":"Pisanti","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.24875\/RIC.23000112_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/molecules27030975","article-title":"Analytical techniques for phytocannabinoid profiling of Cannabis and Cannabis-based products-a comprehensive review","volume":"27","author":"Stefkov","year":"2022","journal-title":"Molecules"},{"key":"10.24875\/RIC.23000112_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in Cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.24875\/RIC.23000112_bib10","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.3390\/ijerph120809988","article-title":"E-cigarettes: a review of new trends in Cannabis use","volume":"12","author":"Giroud","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"10.24875\/RIC.23000112_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.24875\/RIC.23000112_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.24875\/RIC.23000112_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid Type 2 receptors mediate a cell type-specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"10.24875\/RIC.23000112_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.24875\/RIC.23000112_bib15","unstructured":"United Nations. World Drug Report 2020 United Nations. World Drug Report 2020 (United Nations Publication, Sales No. E.20. XI.6; 2020."},{"key":"10.24875\/RIC.23000112_bib16","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.24875\/RIC.23000112_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.survophthal.2020.07.002","article-title":"Cannabinoids and the eye","volume":"66","author":"Wang","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.24875\/RIC.23000112_bib18","article-title":"The relationship between plasma tetrahydrocannabinol levels and intraocular pressure in healthy adult subjects","volume":"8","author":"Mosaed","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.24875\/RIC.23000112_bib19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11606-019-05235-9","article-title":"Acute cardiovascular effects of marijuana use","volume":"35","author":"Ghasemiesfe","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.24875\/RIC.23000112_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061925","article-title":"The impact of marijuana on the cardiovascular system: a review of the most common cardiovascular events associated with marijuana use","volume":"9","author":"Latif","year":"2020","journal-title":"J Clin Med"},{"key":"10.24875\/RIC.23000112_bib21","first-page":"571","article-title":"Cannabis hyperemesis syndrome: an update on the pathophysiology and management","volume":"33","author":"Perisetti","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"10.24875\/RIC.23000112_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000339072","article-title":"The gastrointestinal pharmacology of cannabinoids: focus on motility","volume":"90","author":"Abalo","year":"2012","journal-title":"Pharmacology"},{"key":"10.24875\/RIC.23000112_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainres.2008.06.069","article-title":"Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats","volume":"1228","author":"Smirnov","year":"2008","journal-title":"Brain Res"},{"key":"10.24875\/RIC.23000112_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review. Cannabis","volume":"2","author":"Hill","year":"2017","journal-title":"Cannabinoid Res"},{"key":"10.24875\/RIC.23000112_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2772005pe15","article-title":"Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies","volume":"2005","author":"Sharkey","year":"2005","journal-title":"Sci STKE"},{"key":"10.24875\/RIC.23000112_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19063174","article-title":"Effects of \u03949-tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review","volume":"19","author":"Fearby","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.24875\/RIC.23000112_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.623672","article-title":"Acute effects of Cannabis concentrate on motor control and speed: smartphone-based mobile assessment","volume":"11","author":"Hitchcock","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.24875\/RIC.23000112_bib28","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1007\/s12035-016-0313-5","article-title":"Endocannabinoid system: the direct and indirect involvement in the memory and learning processes-a short review","volume":"54","author":"Kruk-Slomka","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.24875\/RIC.23000112_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-012-2915-6","article-title":"Acute effects of THC on time perception in frequent and infrequent Cannabis users","volume":"226","author":"Sewell","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.24875\/RIC.23000112_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.copsyc.2021.03.003","article-title":"Cannabis and driving ability","volume":"38","author":"Sevigny","year":"2021","journal-title":"Curr Opin Psychol"},{"key":"10.24875\/RIC.23000112_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and Cannabis use disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.24875\/RIC.23000112_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/FBP.0000000000000154","article-title":"Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour","volume":"26","author":"Rodriguez-Manzo","year":"2015","journal-title":"Behav Pharmacol"},{"key":"10.24875\/RIC.23000112_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of \u03949-tetrahydrocannabinol on the dopamine system","volume":"17","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"key":"10.24875\/RIC.23000112_bib34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neuropharm.2005.03.016","article-title":"Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction","volume":"48","author":"Lupica","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.24875\/RIC.23000112_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.24875\/RIC.23000112_bib36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1101\/lm.046870.117","article-title":"Highway to hell or magic smoke? The dose-dependence of \u03949-THC in place conditioning paradigms","volume":"25","author":"Kubilius","year":"2018","journal-title":"Learn Mem"},{"key":"10.24875\/RIC.23000112_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/pha0000457","article-title":"Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates","volume":"29","author":"Cooper","year":"2021","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.24875\/RIC.23000112_bib38","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1017\/S1461145713000709","article-title":"Biphasic effects of \u03949-tetrahydrocannabinol on brain stimulation reward and motor activity","volume":"16","author":"Katsidoni","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.24875\/RIC.23000112_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/M18-0522","article-title":"Marijuana use, respiratory symptoms, and pulmonary function: a systematic review and meta-analysis","volume":"169","author":"Ghasemiesfe","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.24875\/RIC.23000112_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrcardio.2017.130","article-title":"Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly","volume":"15","author":"Pacher","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.24875\/RIC.23000112_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/can.2020.0065","article-title":"The effects of Cannabis on female reproductive health across the life course. Cannabis","volume":"6","author":"Corsi","year":"2021","journal-title":"Cannabinoid Res"},{"key":"10.24875\/RIC.23000112_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.596601","article-title":"Cannabis and cognitive functioning: from acute to residual effects, from randomized controlled trials to prospective designs","volume":"12","author":"Bourque","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.24875\/RIC.23000112_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.euroneuro.2020.03.012","article-title":"Adolescent Cannabis use, cognition, brain health and educational outcomes: a review of the evidence","volume":"36","author":"Lorenzetti","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.24875\/RIC.23000112_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11121-017-0811-3","article-title":"Testing the amotivational syndrome: marijuana use longitudinally predicts lower self-efficacy even after controlling for demographics, personality, and alcohol and cigarette use","volume":"19","author":"Lac","year":"2018","journal-title":"Prev Sci"},{"key":"10.24875\/RIC.23000112_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of Cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.24875\/RIC.23000112_bib46","article-title":"The association between Cannabis use and schizophrenia: causative or curative? A systematic review","volume":"12","author":"Patel","year":"2020","journal-title":"Cureus"},{"key":"10.24875\/RIC.23000112_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.625158","article-title":"Down and high: reflections regarding depression and Cannabis","volume":"12","author":"Langlois","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.24875\/RIC.23000112_bib48","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1017\/S0033291713001438","article-title":"The association between Cannabis use and depression: a systematic review and meta-analysis of longitudinal studies","volume":"44","author":"Lev-Ran","year":"2014","journal-title":"Psychol Med"},{"key":"10.24875\/RIC.23000112_bib49","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpsychires.2007.01.002","article-title":"Specificity of social anxiety disorder as a risk factor for alcohol and Cannabis dependence","volume":"42","author":"Buckner","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.24875\/RIC.23000112_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12888-020-02813-8","article-title":"Effects of \u03949-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies","volume":"20","author":"Raymundi","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.24875\/RIC.23000112_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cpr.2011.01.006","article-title":"Prospective association of childhood attention-deficit\/hyperactivity disorder (ADHD) and substance use and abuse\/dependence: a metaanalytic review","volume":"31","author":"Lee","year":"2011","journal-title":"Clin Psychol Rev"},{"key":"10.24875\/RIC.23000112_bib52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.addbeh.2016.04.018","article-title":"Association between schizotypal and borderline personality disorder traits, and Cannabis use in young adults","volume":"60","author":"Raynal","year":"2016","journal-title":"Addict Behav"},{"key":"10.24875\/RIC.23000112_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.07.014","article-title":"Cannabis use and the development of tolerance: a systematic review of human evidence","volume":"93","author":"Colizzi","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.24875\/RIC.23000112_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","article-title":"Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history","volume":"227","author":"Bonini","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"10.24875\/RIC.23000112_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.24875\/RIC.23000112_bib56","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.24875\/RIC.23000112_bib57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1474-4422(19)30032-8","article-title":"Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders","volume":"18","author":"Friedman","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.24875\/RIC.23000112_bib58","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yebeh.2018.07.027","article-title":"Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: a randomized, double-blind, controlled trial","volume":"88","author":"Schoedel","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.24875\/RIC.23000112_bib59","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug-drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J Clin Med"},{"key":"10.24875\/RIC.23000112_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.24875\/RIC.23000112_bib61","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A Phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.24875\/RIC.23000112_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28073271","article-title":"The polypharmacological effects of cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Molecules"},{"key":"10.24875\/RIC.23000112_bib63","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.24875\/RIC.23000112_bib64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.24875\/RIC.23000112_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.24875\/RIC.23000112_bib66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-011-2495-x","article-title":"Interaction between cannabidiol (CBD) and \u0394(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids","volume":"219","author":"Zuardi","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.24875\/RIC.23000112_bib67","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA"},{"key":"10.24875\/RIC.23000112_bib68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000521683","article-title":"Therapeutic potential of Cannabis, cannabidiol, and cannabinoid-based pharmaceuticals","volume":"107","author":"Legare","year":"2022","journal-title":"Pharmacology"},{"key":"10.24875\/RIC.23000112_bib69","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, Engineering, and Medicine","year":"2017"},{"key":"10.24875\/RIC.23000112_bib70","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110","article-title":"Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis","volume":"125","author":"Meng","year":"2017","journal-title":"Anesth Analg"},{"key":"10.24875\/RIC.23000112_bib71","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.24875\/RIC.23000112_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"McGuire","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.24875\/RIC.23000112_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front Psychol"},{"key":"10.24875\/RIC.23000112_bib74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-019-9277-x","article-title":"A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome","volume":"11","author":"Heussler","year":"2019","journal-title":"J Neurodev Disord"},{"key":"10.24875\/RIC.23000112_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.24875\/RIC.23000112_bib76","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation","volume":"18","author":"Zuardi","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.24875\/RIC.23000112_bib77","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.2174\/138161212802884744","article-title":"The endocannabinoid system and schizophrenia: integration of evidence","volume":"18","author":"Zamberletti","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.24875\/RIC.23000112_bib78","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.24875\/RIC.23000112_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbr.2016.04.042","article-title":"Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice","volume":"309","author":"Sonego","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.24875\/RIC.23000112_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.24875\/RIC.23000112_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.24875\/RIC.23000112_bib82","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"key":"10.24875\/RIC.23000112_bib83","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.24875\/RIC.23000112_bib84","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.24875\/RIC.23000112_bib85","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","article-title":"The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling","volume":"135","author":"Fogaca","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.24875\/RIC.23000112_bib86","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.24875\/RIC.23000112_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000443890","article-title":"Prohedonic effect of cannabidiol in a rat model of depression","volume":"73","author":"Shoval","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.24875\/RIC.23000112_bib88","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of Cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1\u00b0) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.24875\/RIC.23000112_bib89","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00001756-200204160-00006","article-title":"Cannabidiol, a non-psychoactive component of Cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats","volume":"13","author":"Parker","year":"2002","journal-title":"Neuroreport"},{"key":"10.24875\/RIC.23000112_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.989717","article-title":"Cannabidiol for neurodegenerative disorders: a comprehensive review","volume":"13","author":"Bhunia","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.24875\/RIC.23000112_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.24875\/RIC.23000112_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.24875\/RIC.23000112_bib93","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2011.03.053","article-title":"Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia","volume":"222","author":"Gururajan","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.24875\/RIC.23000112_bib94","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2011.04.017","article-title":"Cannabis with high cannabidiol content is associated with fewer psychotic experiences","volume":"130","author":"Schubart","year":"2011","journal-title":"Schizophr Res"},{"key":"10.24875\/RIC.23000112_bib95","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41386-022-01478-z","article-title":"Does cannabidiol make Cannabis safer? A randomized, double-blind, cross-over trial of Cannabis with four different CBD:THC ratios","volume":"48","author":"Englund","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"10.24875\/RIC.23000112_bib96","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.24875\/RIC.23000112_bib97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and anti-inflammatory properties of cannabidiol","volume":"9","author":"Atalay","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.24875\/RIC.23000112_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","article-title":"The emerging functions of endocannabinoid signaling during CNS development","volume":"28","author":"Harkany","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.24875\/RIC.23000112_bib99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.24875\/RIC.23000112_bib100","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2020.1762539","article-title":"The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review","volume":"50","author":"Alves","year":"2020","journal-title":"Crit Rev Toxicol"}],"container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003483762500141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003483762500141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.clinicalandtranslationalinvestigation.com\/frame_esp.php?id=462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:01:39Z","timestamp":1751371299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003483762500141X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S003483762500141X"],"URL":"https:\/\/doi.org\/10.24875\/ric.23000112","relation":{},"ISSN":["0034-8376"],"issn-type":[{"value":"0034-8376","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin","name":"articletitle","label":"Article Title"},{"value":"Revista de Investigaci\u00f3n Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24875\/RIC.23000112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Revista de Investigaci\u00f3n Cl\u00ednica. Published by Permanyer. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}